We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aptamer Group Plc | LSE:APTA | London | Ordinary Share | GB00BNRRP542 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.37 | 0.36 | 0.38 | 0.37 | 0.37 | 0.37 | 4,445,637 | 08:00:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 860k | -2.96M | -0.0015 | -2.47 | 7.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/11/2024 16:24 | It really is the proverbial NB! Ran out of top-up money last week. Pleased as punch I'm up to my neck in it. | thedickster | |
08/11/2024 16:22 | 2v1 now selling above mid they want stock | bones698 | |
08/11/2024 16:08 | I added yesterday. As you say Parob, the chart looks great. It's all coming together. What could possibly go wrong :-)) | walter walcarpets | |
08/11/2024 15:55 | Look at the recent share options they announced at multiples of today's share price . They expect this to be a lot lot higher in the near future imo 0.3p next offer level 2 1v1 now won't take much for this to pop imo Huge gap on the chart to 0.6p | bones698 | |
08/11/2024 15:37 | Not long now before this one gets noticed imo after the two very positive RNS this week. Hardly getting a mention in the telegram groups at the moment. Chart starting to look very good too.Well worth a read of that research note I just posted. As bones just said based just on their fee for service business they should have enough cash until mid 2026 but what happens if they announce a licensing deal before then with the likes of Unilever, Astrazeneca or another pharma company. | parob | |
08/11/2024 15:20 | All fantastic stuff and at 4m mkt cap with 3 m in the bank it's free money for those that are patient . Cash until middle of 2026 is better than many companies can say . I'll add as funds become available. At these levels it's a no brainer with huge potential and all very positive . The cash runway is excellent | bones698 | |
08/11/2024 15:10 | Have a read of this research note. You are getting so much for just over £4M MCap imo. Don't think we necessarily need more news soon for this to go on a strong run. hTTps://x.com/robjoh | parob | |
08/11/2024 12:02 | The share price will attack the 0.4 p level soon. | kingston78 | |
08/11/2024 07:40 | Aptamer CEO Dr Arron Tolley on extended deal with genetic medicines customer; growing pipeline | someuwin | |
07/11/2024 14:12 | Bones Yep seen that MMs want some stock they are getting twitchy | gepetto100 | |
07/11/2024 14:08 | Can swell above mid . Looks like mms wants stock probably before a big move imo | bones698 | |
07/11/2024 13:13 | The start of a decent climb from here now the seller is out imo and investors are less likely to sell knowing a licensing deal might not be that far off. | parob | |
07/11/2024 12:14 | The spread is wide, but I think that you could double your money easily. | kingston78 | |
07/11/2024 12:06 | Still very under the radar ATM but the seller has gone finally so that should see this move up quickly on any buying volumes . | bones698 | |
07/11/2024 10:38 | Bought a few more this morning also !! | parsons4 | |
07/11/2024 09:23 | Nobody noticed but they announced 471k of deals yesterday yet stayed they still had 4m in pipeline work to be signed . This shows that the pipeline work has grown again and was upto 4.5m imo . Just a little thing that slipped through unnoticed imo | bones698 | |
07/11/2024 08:30 | Totally agree parob any form of licensing deals will see this rerate . Seller looks to have cleared too so this should continue to rise in decent chunks . The sales team are motivated and getting customers in a hurry too . New management team certainly seem to be driving this in the right direction . | bones698 | |
07/11/2024 08:30 | This company has great potential. Strong buy. | kingston78 | |
07/11/2024 08:27 | I sold FDEV this morning and added a few here. Way above my recent buy in price but I thought the news was worth it.If the seller is cleared, this could really move as bones mentions, and I think the anticipation of a licensing deal now we are getting close will drive this higher too. | parob | |
07/11/2024 08:19 | The revenues could be double digit millions from that alone . Will take time but this is looking like a bargain . Seller cleared this is starting to move quickly back to 0.6p range for a start | bones698 | |
07/11/2024 08:18 | Moving - mms have broadened the spread in anticipation of | gepetto100 | |
07/11/2024 08:15 | I agree Parob about the mentioning of AZ again.There is an air of confidence around Dr Arran Tolley in relation to this The expectation has risen over the last few months as they have progressed through the stages with AZ and there seems to be a willingness on AZ to move forward rapidly It would be a ground breaking announcement | gepetto100 | |
07/11/2024 08:11 | Seller cleared ? This could motor if they have done | bones698 | |
07/11/2024 07:47 | As this Optimer advances through the final development stages, we continue to move closer to demonstrating the strength of our Optimer platform in generating high-value, therapeutic targeting assets.Market cap currently just over £4M | parob | |
07/11/2024 07:31 | Parob I think we are only in this trading range due to one of the share placing holders selling ,possibly the warrants issued as part of the raise . Once cleared this will move imo . Mkt cap is comical compared to others in the sector. How many have all the top 10 pharma cos as customers and 15 of the top 20 Fgs I would have liked to have known what impact that has on reenues can only be positive as they build and develop these partnerships | bones698 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions